share_log

君聖泰醫藥-B：自願性公告股價不尋常波動

HIGHTIDE-B: VOLUNTARY ANNOUNCEMENTUNUSUAL PRICE MOVEMENTS

HKEX ·  Jun 24 19:22
Summary by Futu AI
君圣泰医药（HighTide Therapeutics, Inc.）於2024年6月24日發佈自願性公告，指出公司股份近期出現不尋常波動。董事會經合理查詢後確認，截至公告時間，並不知悉導致股價波動的具體原因，亦無需披露的資料或內幕消息。公司業務運營和財務狀況維持正常，無重大不利變動。公司股東及潛在投資者應謹慎處理買賣公司證券。公告由執行董事兼行政總裁劉利平博士代表董事會發出，董事會成員包括執行董事劉利平博士及于萌女士，非執行董事朱迅博士等人。
君圣泰医药（HighTide Therapeutics, Inc.）於2024年6月24日發佈自願性公告，指出公司股份近期出現不尋常波動。董事會經合理查詢後確認，截至公告時間，並不知悉導致股價波動的具體原因，亦無需披露的資料或內幕消息。公司業務運營和財務狀況維持正常，無重大不利變動。公司股東及潛在投資者應謹慎處理買賣公司證券。公告由執行董事兼行政總裁劉利平博士代表董事會發出，董事會成員包括執行董事劉利平博士及于萌女士，非執行董事朱迅博士等人。
On June 24, 2024, HighTide Therapeutics, Inc. released a voluntary announcement stating that the company's shares have recently experienced unusual fluctuations. After reasonable inquiry by the board of directors, as of the time of the announcement, there is no specific reason known for the stock price fluctuations and no information or insider information needs to be disclosed. The company's business operations and financial conditions remain normal with no significant adverse changes. Shareholders and potential investors should exercise caution when buying or selling the company's securities. The announcement was issued by Dr. Liu Liping, CEO and Executive Director of the Board, which includes Executive Director Dr. Liu Liping and Ms. Yu Meng, and non-executive director Dr. Zhu Xun.
On June 24, 2024, HighTide Therapeutics, Inc. released a voluntary announcement stating that the company's shares have recently experienced unusual fluctuations. After reasonable inquiry by the board of directors, as of the time of the announcement, there is no specific reason known for the stock price fluctuations and no information or insider information needs to be disclosed. The company's business operations and financial conditions remain normal with no significant adverse changes. Shareholders and potential investors should exercise caution when buying or selling the company's securities. The announcement was issued by Dr. Liu Liping, CEO and Executive Director of the Board, which includes Executive Director Dr. Liu Liping and Ms. Yu Meng, and non-executive director Dr. Zhu Xun.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.